Morningstar

Medtronic BrainSense™ Adaptive Deep Brain Stimulation named a 2025 TIME Best Inventions

DUBLIN, Oct. 9, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that BrainSense™ Adaptive Deep Brain Stimulation (aDBS) – the world's first ...
Nasdaq

Medtronic earns U.S. FDA approval for the world's first Adaptive deep brain stimulation system for people with Parkinson's

New closed-loop system self-adjusts DBS therapy to individual brain activity in real time; the largest commercial launch of brain-computer interface technology ever There is no cure for debilitating ...
Morningstar

Reading Your Brain Waves To Treat a Debilitating Disease

Liza Bobrow received her DBS device before the FDA approval of aDBS; however, a software upgrade to aDBS does not require surgery. Her device already includes the brain sensing technology †; if her ...
MobiHealthNews

Medtronic's deep brain stimulation programmer and app get the FDA nod

Medical tech company Medtronic has just landed FDA clearance on its Deep Brain Stimulation (DBS) Clinical Programmer and ActivaProgramming application. "This marks a new era of innovation from the ...
Fierce Healthcare

New Data in the New England Journal of Medicine Show Medtronic Deep Brain Stimulation Provides Sustained Motor Function Im

MINNEAPOLIS--(BUSINESS WIRE)-- In the largest, randomized, controlled study of deep brain stimulation (DBS) for Parkinson’s disease, Medtronic DBS Therapy was shown to improve motor function for up to ...